Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
RGT | Sydney | AUD | Delayed | |
MGCLF | OTC Markets | USD | Delayed | |
RGT | London | GBP | Real-time |
Argent BioPharma Limited, a drug discovery clinical-stage biopharmaceutical company, provides medicines targeting immunology and neurology worldwide. Its principal product candidates include CimetrA, which is in phase II clinical trial for the treatment of SLE Lupus, anti-inflammatory, and SARS COVID-19; and CannEpil, which is in phase I clinical trial for refractory epilepsy and cerebral palsy; and CogniCann, which is in phase I clinical trial for the symptomatic relief of Dementia and Alzheimer. In addition, the company provides Irnican for brain cancer. The company was formerly known as MGC Pharmaceuticals Limited and changed it name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.
Name | Age | Since | Title |
---|---|---|---|
Ross Grant Thomas Walker | - | 2016 | Chairman of Strategic Advisory Board |
Uri Kramer | - | 2016 | Member of Strategic Advisory Board |
Roby Reuven Zomer | 43 | 2016 | Co-Founder, CEO, MD & Executive Director |
Wendyl D’Souza | - | 2018 | Member of Medical Advisory Board |
Layton Patrick Mills | - | 2023 | Independent Non-Executive Director |
Daniel Robinson | - | 2023 | Non-Executive Director |
Shlomo Sadoun | - | 2024 | Member of Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review